Treace Medical Concepts, Inc. (TMCI): Cash & Equivalents

Annual figures by period end, from SEC filings.

$10.71M
As of 2025-12-31
$12.61M
As of 2026-06-30
-18.1%
3-year compound annual growth
-9.9%
5-year compound annual growth
$105.83M2019-12-31: $12.14M2020-12-31: $18.08M2021-12-31: $105.83M2022-12-31: $19.47M2023-12-31: $12.98M2024-12-31: $11.35M2025-12-31: $10.71M$10.71M
2019-12-31 Cash & Equivalents (USD) 2025-12-31
Period endedCash & EquivalentsChange YoYSource filing
2025-12-31$10.71M-5.7%2026-02-27, Balance as of period end
2024-12-31$11.35M-12.6%2026-02-27, Balance as of period end
2023-12-31$12.98M-33.3%2025-02-27, Balance as of period end
2022-12-31$19.47M-81.6%2024-02-27, Balance as of period end
2021-12-31$105.83M+485.4%2023-03-08, Balance as of period end
2020-12-31$18.08M+48.9%2022-03-04, Balance as of period end
2019-12-31$12.14Mn/a2022-03-04, Balance as of period end

Cash & Equivalents at similar companies

Companies with the same SEC industry code (Surgical & Medical Instruments & Apparatus), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCash & EquivalentsChange YoY
Treace Medical Concepts, Inc. (TMCI)2025-12-31$10.71M-5.7%
SI-BONE, Inc. (SIBN)2025-12-31$42.24M+20.9%
Cerus Corp (CERS)2025-12-31$19.96M-1.5%
Orthopediatrics Corp (KIDS)2025-12-31$19.56M-55.4%
Lemaitre Vascular Inc (LMAT)2025-12-31$28.24M+10.3%
Heartflow, Inc. (HTFL)2025-12-31$44.78M-12.8%
Neuronetics, Inc. (STIM)2025-12-31$28.13M+52.4%
PROCEPT BioRobotics Corp (PRCT)2025-12-31$286.50M-14.1%
InfuSystem Holdings, Inc (INFU)2025-12-31$3.19M+504.6%

Compare TMCI, SIBN, CERS, KIDS side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗